Key result
This review discusses various studies and guidelines regarding the management of anticoagulant therapy in patients with mechanical heart valves to formulate recommendations for daily clinical practice.
Why the study?
How should anticoagulant therapy be managed in patients with mechanical heart valves across various clinical scenarios?
How should anticoagulant therapy be managed in patients with mechanical heart valves across various clinical scenarios?
This review provides practical recommendations for managing anticoagulant therapy in patients with mechanical heart valves, addressing optimal VKA intensity, noncardiac surgery, and pregnancy.
May inform anticoagulant decisions in mechanical valve patients; extends guideline synthesis but leaves optimal regimens open.
There is a wide array of recommendations for the management of anticoagulant therapy in patients with mechanical heart valves. The optimal intensity of vitamin K antagonists, management of patients during noncardiac surgery and use of anticoagulants during pregnancy are all ongoing matters of debate. In this review, we discuss the various studies on these topics and the different guidelines. Based on these, literature recommendations for daily clinical practice are formulated.
No takes yet. Share an insight, caveat, or question.
Vink et al. (2007) conducted a review in Mechanical heart valves. Anticoagulant therapy was evaluated. This review discusses various studies and guidelines regarding the management of anticoagulant therapy in patients with mechanical heart valves to formulate recommendations for daily clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: